Suppression of GFAP toxicity by αB-crystallin in mouse models of Alexander disease
Open Access
- 7 January 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 18 (7), 1190-1199
- https://doi.org/10.1093/hmg/ddp013
Abstract
Alexander disease (AxD) is a primary disorder of astrocytes caused by dominant mutations in the gene for glial fibrillary acidic protein (GFAP). These mutations lead to protein aggregation and formation of Rosenthal fibers, complex astrocytic inclusions that contain GFAP, vimentin, plectin, ubiquitin, Hsp27 and αB-crystallin. The small heat shock protein αB-crystallin (Cryab) regulates GFAP assembly, and elevation of Cryab is a consistent feature of AxD; however, its role in Rosenthal fibers and AxD pathology is not known. Here, we show in AxD mouse models that loss of Cryab results in increased mortality, whereas elevation of Cryab rescues animals from terminal seizures. When mice with Rosenthal fibers induced by over-expression of GFAP are crossed into a Cryab-null background, over half die at 1 month of age. Restoration of Cryab expression through the GFAP promoter reverses this outcome, showing the effect is astrocyte-specific. Conversely, in mice engineered to express both AxD-associated mutations and elevated GFAP, which despite natural induction of Cryab also die at 1 month, transgenic over-expression of Cryab results in a markedly reduced CNS stress response, restores expression of the glutamate transporter Glt1 (EAAT2) and protects these animals from death. In its most common form, AxD is a devastating neurodegenerative disease, with early onset, characterized by seizures, spasticity and developmental delays, ultimately leading to death. Cryab plays a critical role in tempering AxD pathology and should be investigated as a therapeutic target for this and other diseases with astropathology.This publication has 53 references indexed in Scilit:
- Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathwaysHuman Molecular Genetics, 2008
- Interactive sequences in the stress protein and molecular chaperone human αB crystallin recognize and modulate the assembly of filamentsThe International Journal of Biochemistry & Cell Biology, 2007
- Glial cells as intrinsic components of non-cell-autonomous neurodegenerative diseaseNature Neuroscience, 2007
- Hsp27 (HspB1) and αB‐crystallin (HspB5) as therapeutic targetsFEBS Letters, 2007
- The Alexander Disease–Causing Glial Fibrillary Acidic Protein Mutant, R416W, Accumulates into Rosenthal Fibers by a Pathway That Involves Filament Aggregation and the Association of αB-Crystallin and HSP27American Journal of Human Genetics, 2006
- Modulation of neurodegeneration by molecular chaperonesNature Reviews Neuroscience, 2005
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Nuclear speckle localisation of the small heat shock protein αB-crystallin and its inhibition by the R120G cardiomyopathy-linked mutationExperimental Cell Research, 2003
- Interaction between αB-crystallin and the human 20S proteasomal subunit C8/α7Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2001
- Identification and Characterization of the Gene Encoding a New Member of the α-Crystallin/Small hsp Family, Closely Linked to the αB-Crystallin Gene in a Head-to-Head MannerGenomics, 1997